Oligodendrocyte death, neuroinflammation, and the effects of minocycline in a rodent model of nonarteritic anterior ischemic optic neuropathy (rNAION)
Open Access
- 17 December 2017
- journal article
- Vol. 23, 963-976
Abstract
Optic nerve (ON) damage following nonarteritic anterior ischemic optic neuropathy (NAION) and its models is associated with neurodegenerative inflammation. Minocycline is a tetracycline derivative antibiotic believed to exert a neuroprotective effect by selective alteration and activation of the neuroinflammatory response. We evaluated minocycline’s post-induction ability to modify early and late post-ischemic inflammatory responses and its retinal ganglion cell (RGC)–neuroprotective ability. We used the rodent NAION (rNAION) model in male Sprague-Dawley rats. Animals received either vehicle or minocycline (33 mg/kg) daily intraperitoneally for 28 days. Early (3 days) ON-cytokine responses were evaluated, and oligodendrocyte death was temporally evaluated using terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) analysis. Cellular inflammation was evaluated with immunohistochemistry, and RGC preservation was compared with stereology of Brn3a-positive cells in flat mounted retinas. Post-rNAION, oligodendrocytes exhibit a delayed pattern of apoptosis extending over a month, with extrinsic monocyte infiltration occurring only in the primary rNAION lesion and progressive distal microglial activation. Post-induction minocycline failed to improve retinal ganglion cell survival compared with the vehicle treated (893.14 vs. 920.72; p>0.9). Cytokine analysis of the rNAION lesion 3 days post-induction revealed that minocycline exert general inflammatory suppression without selective upregulation of cytokines associated with the proposed alternative or neuroprotective M2 inflammatory pathway. The pattern of cytokine release, extended temporal window of oligodendrocyte death, and progressive microglial activation suggests that selective neuroimmunomodulation, rather than general inflammatory suppression, may be required for effective repair strategies in ischemic optic neuropathies.Keywords
This publication has 43 references indexed in Scilit:
- The effect of intravenous interleukin-1 receptor antagonist on inflammatory mediators in cerebrospinal fluid after subarachnoid haemorrhage: a phase II randomised controlled trialJournal of Neuroinflammation, 2014
- Microglial Responses after Ischemic Stroke and Intracerebral HemorrhageJournal of Immunology Research, 2013
- Minocycline selectively inhibits M1 polarization of microgliaCell Death & Disease, 2013
- PGJ2 Provides Prolonged CNS Stroke Protection by Reducing White Matter EdemaPLOS ONE, 2012
- Cellular Inflammation in Nonarteritic Anterior Ischemic Optic Neuropathy and Its Primate ModelArchives of Ophthalmology (1950), 2011
- Role of Microglia in NeurotraumaNeurotherapeutics, 2010
- Polarization dictates iron handling by inflammatory and alternatively activated macrophagesHaematologica, 2010
- Astrocytes: biology and pathologyActa Neuropathologica, 2009
- Optic nerve infarction and post-ischemic inflammation in the rodent model of anterior ischemic optic neuropathy (rAION)Brain Research, 2009
- Rodent Anterior Ischemic Optic Neuropathy (rAION) Induces Regional Retinal Ganglion Cell Apoptosis with a Unique Temporal PatternInvestigative Ophthalmology & Visual Science, 2008